Bladder papillary urothelial carcinoma
MONDO:0004056An invasive or non-invasive papillary transitional cell carcinoma of the urinary bladder. It is classified as low - or high-grade. -- 2003
Also known as: bladder papillary urothelial carcinoma, urinary bladder papillary transitional cell carcinoma, urothelial papillary carcinoma of the bladder, bladder urothelial papillary carcinoma
2780 clinical trials for this condition and its sub-types, 11 tagged with Bladder papillary urothelial carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug combo aims to control bladder cancer when standard therapy fails
Disease control Recruiting nowThis study tests two drugs, durvalumab and monalizumab, given together to people with a type of bladder cancer that has not gotten better with standard treatment. The goal is to see if the combination can make the cancer disappear or stop it from growing. About 60 adults will tak…
Phase 2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New bladder cancer drug shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called PF-08052667 for adults with a type of bladder cancer that hasn't spread into the muscle layer but is likely to return. The drug is given directly into the bladder, sometimes with other medicines like BCG or sasanlimab. The trial has three parts …
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for bladder cancer patients: experimental drug combo aims to beat chemo
Disease control Recruiting nowThis Phase 3 trial is testing whether a combination of an experimental drug (SHR-1501) plus the standard immunotherapy BCG works better than chemotherapy for people with a type of bladder cancer (papillary-only NMIBC) that no longer responds to BCG alone. The study plans to enrol…
Phase 3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New bladder cancer gel shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called STM-416 that is applied directly to the bladder during surgery to remove tumors. It is for people with a type of bladder cancer that keeps coming back. The goal is to see if the drug is safe and can help keep the cancer from returning. About 75 …
Phase 1/2 • Sponsor: SURGE Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New virus therapy takes on tough bladder cancer
Disease control Recruiting nowThis phase 2 trial is testing a treatment called cretostimogene grenadenorepvec, a modified virus designed to infect and destroy cancer cells, in 16 people with high-risk bladder cancer that has not responded to standard BCG therapy. The study aims to see if the treatment can mak…
Phase 2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Bladder cancer patients may avoid surgery with new drug combo
Disease control Recruiting nowThis phase 2 trial is testing whether two chemotherapy drugs, gemcitabine and docetaxel, given directly into the bladder can treat high-risk bladder cancer that did not respond to standard BCG therapy. About 174 adults will receive weekly treatments for 6 weeks, then monthly for …
Phase 2 • Sponsor: Michael A. O'Donnell • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Bladder cancer breakthrough? new drug combo aims to stop tumors returning
Disease control Recruiting nowThis phase 2 trial tests whether giving two chemotherapy drugs (gemcitabine and docetaxel) directly into the bladder can prevent low-grade bladder cancer from coming back. About 34 adults with intermediate-risk disease will receive the treatment. The main goal is to see how long …
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New MRI dye could help doctors see bladder cancer depth without surgery
Diagnosis Recruiting nowThis early-phase study tests a new MRI technique that uses two contrast agents (gadobutrol and ferumoxytol) placed directly into the bladder to improve staging of bladder cancer. Researchers will compare MRI images to actual tumor samples from surgery to see if the scan can accur…
Early phase 1 • Sponsor: Jodi Maranchie • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC